BeatPark: Self-rehabilitation in Walking With Parkinson's Disease
NCT ID: NCT04543058
Last Updated: 2024-06-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
396 participants
INTERVENTIONAL
2020-09-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The rhythm of music makes you want to move whether you are sick or not. In addition, it has been found that in people with PD, it can also improve walking by helping the participant to regain the regularity of alternating steps and a better walking dynamic (i.e. better position, better arm swinging, etc.). Studies have shown that music allows persons with PD to walk faster, with bigger steps.
However, if the tempo of the music does not correspond to the participant's walking pace, instead of helping him, it can disturb him. So it seems necessary for music to help people with PD to walk better if the tempo of the music is set to match their steps.
BeatPark is a smartphone application which makes it possible to synchronize the tempo of the music with the participant's walking rhythm detected thanks to feet insoles. Once synchronized to the participant's walking pace, BeatPark imperceptibly accelerates the tempo of the music to help the participant's acceleration.
This clinical trial proposes to study the effects of walking rehabilitation depending on the use of music synchronized to the participant's step with BeatPark, music with random tempo or without music.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Proof of Concept BeatPark
NCT02647242
Exercise Study For People With Parkinson's Disease
NCT00387218
A Training of the Rhythmic Skills With a Serious Game to Improve Gait and Cognitive Abilities in Parkinson's Disease
NCT02855710
Evaluation of a Personalized Physical Activity Coaching Program in Parkinson's Disease
NCT02816619
Feasibility and Preliminary Effects of MR-005 in Persons With Parkinson Disease
NCT04891107
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Visit 0 (inclusion visit)
* Verification of inclusion and non-inclusion criteria
* Signature of consent
* Information gathering
* Demographic information (date of birth, height, weight, activity, etc.) professional).
* Clinical information about the disease (age of onset and duration of the disease, treatments and their distribution).
* Medical history including present or past medical conditions and any other conditions that may be relevant to the study and their treatment.
* Neurological examination with MDS-UPDRS (Movement Disorder Society - Unified Parkinson's Disease Rating Scale) and NFOG-Q (New Freezing of Gait-Questionnaire) scales
* Explanation and delivery of the agenda for the next 2 weeks
* "Feetme(c)" soles in place
* Remittance of self-questionnaires for a home refill before V1
2. Base Line From the day of inclusion until visit 1 the patient will complete a diary to record the occurrence of falls and freezing, and to self-assess on a visual numerical scale their levels of pain, fatigue and motivation.
3. Visit 1 (week 2)
* Run the 6 minutes test in silence.
* Actualization of the Battery for the Assessment of Auditory Sensorimotor and Timing Abilities (BAASTA).
* Collecting and checking the completeness of the different scales given at visit 0 and helping to fill in incomplete scales.
* Information and training in the use of the BeatPark device (programmed with or without music according to randomization)
* Explanation of the self-education program (number of sessions, duration, location...) for the 4 weeks.
* Delivery of questionnaires to be completed within 3 days prior to the visit 2.
* MRI: morphological sequences (T1 3D, T2 FLAIR, T2\*) and functional sequences (Resting state and with the different types of auditory indication) for the subgroup explored in imaging.
4. Intervention phase
\*Self-reeducation program:
* This program will consist of walking outdoors for 5 sessions of 30 minutes per week for 4 consecutive weeks with the BeatPark device (set to deliver music or not, adapted music or random tempo).
\* Phone call:
* The clinical research associate (CRA) will contact the patient to ensure the proper functioning and compliance with the rehabilitation program, if any difficulties are encountered.
\*Self-assessment schedule:
* From the day of visit 1 through visit 2 the participant will complete a diary to record the occurrence of falls and freezing, and to self-assess on a visual numerical scale their levels of pain, fatigue, motivation and satisfaction.
5. Visit 2 (end-of-study visit, week 4):
* Neurological evaluation with the MDS-UPDRS, NFOG and CGI (Clinical Global Impression) scales.
* Running the 6 minutes test in silence
* Achievement of the BAASTA
* Collection and verification of the completeness of the different scales submitted to V1 (and completed within the last 3 days) and helps to fill in incomplete scales
* Checking for no change in anti-parkinsonian treatment.
* Return the equipment to the investigation team.
* MRI: morphological sequences (T1 3D, T2 FLAIR, T2\*) and functional sequences (Resting, T2 FLAIR, T2\*). state and with the different types of auditory indication))) for the subgroup explored in imagery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BeatPark Experimental Group
Group of participants who will make its self-rehabilitation in walking program using BeatPark application, delivering synchronized music adapted to the patient walking progression.
BeatPark Application
The participant walks for 30 minutes a day, 5 day a week for 4 weeks. During the walking session, BeatPark Application delivers synchronized music adapted to the patient walking.
The application allows participants to know the progress of their session through graphical representation and voice messages, informs them at the end of the session of their performance and congratulate them for their efforts.
Control Group with Music at Random Tempo
Group of participants who will make its self-rehabilitation in walking program using an application delivering music at random tempo.
BeatPark Application without synchronized music
The participant walks for 30 minutes a day, 5 days a week for 4 weeks. During the walking session, BeatPark Application delivers random music at random tempo.
The application allows participants to know the progress of their session through graphical representation and voice messages, informs them at the end of the session of their performance and congratulate them for their efforts.
Control Group without Music
Group of participants who will make its self-rehabilitation in walking program using an application without music.
BeatPark Application without music
The participant walks for 30 minutes a day, 5 days a week for 4 weeks. During the walking session, BeatPark Application does not deliver music. The application allows participants to know the progress of their session through graphical representation and voice messages, informs them at the end of the session of their performance and congratulate them for their efforts.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BeatPark Application
The participant walks for 30 minutes a day, 5 day a week for 4 weeks. During the walking session, BeatPark Application delivers synchronized music adapted to the patient walking.
The application allows participants to know the progress of their session through graphical representation and voice messages, informs them at the end of the session of their performance and congratulate them for their efforts.
BeatPark Application without synchronized music
The participant walks for 30 minutes a day, 5 days a week for 4 weeks. During the walking session, BeatPark Application delivers random music at random tempo.
The application allows participants to know the progress of their session through graphical representation and voice messages, informs them at the end of the session of their performance and congratulate them for their efforts.
BeatPark Application without music
The participant walks for 30 minutes a day, 5 days a week for 4 weeks. During the walking session, BeatPark Application does not deliver music. The application allows participants to know the progress of their session through graphical representation and voice messages, informs them at the end of the session of their performance and congratulate them for their efforts.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have a walking disorder defined by the neurologist (Item 10 of the MDSUPDRS-III ≥1);
* Be able to walk 30 consecutive minutes without technical assistance (e.g. cane or walker) or human assistance;
* Receive an uninterrupted antiparkinsonian pharmacological treatment since one month (and throughout the study period).
* Be over 35 and under 95 of age;
* Be able to understand the nature, purpose and methodology of the study and agree to cooperate during assessments;
* Have signed the informed consent;
* Be affiliated to a social security plan or affiliated to such a equivalent health plan.
Non-Inclusions:
* Presence of signs in favor of an atypical parkinsonian syndrome (involvement oculomotor, early falls, hallucinations, Montreal Cognitive Assessment \<21/30, severe and early dysautonomia);
* Have a hearing impairment;
* Have any other neurological damage that affects walking;
* Have a walking disorder of other origin (e.g. orthopedic, rheumatological, etc.);
* Have severe or unbalanced heart or respiratory Failure which contraindicates walk rehabilitation.
* Adult under legal protection or unfit to express their consent (Article 1121-8 of the CSP);
* Vulnerable people (Article L 1121-6 of the CSP);
* Loss of liberty by judicial or administrative decision;
* High probability of non-compliance with the protocol or abandonment during the study;
* Pregnant / lactating women.
* Pacemaker or neurosensory stimulator or implantable defibrillator;
* Cochlear implants;
* Foreign ferromagnetic ocular or cerebral bodies close to nervous structures
* Metal prosthesis;
* Agitation of the participants: non-cooperative or agitated participants;
* Claustrophobic participants;
* Pregnant woman;
* Ventriculo-peritoneal neurosurgical bypass valves;
* Braces.
Exclusion Criteria
* A change in the background treatment of PD will not systematically justify leaving the study but will be evaluated by the scientific committee on a case-by-case basis.
36 Years
94 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Team Languedoc Mutualité / Nouvelles technologies
UNKNOWN
University Hospital, Montpellier
OTHER
Euromov, Montpellier Univeristy
UNKNOWN
Université de Montréal
OTHER
AxLR SATT
UNKNOWN
Clinique Beau Soleil
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Valérie Cohen, M.D.
Role: PRINCIPAL_INVESTIGATOR
Clinique Beau Soleil
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Beau Soleil
Montpellier, Hérault, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A02032-55
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.